Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
P2RY14 |
purinergic receptor P2Y, G-protein coupled, 14, transcript variant 2 |
FXC00001
|
FHC00001
|
FNC00001N
|
FNC00001C
|
DRD1 |
dopamine receptor D1 |
FXC00007
|
FHC00007
|
FNC00007N
|
FNC00007C
|
GPRIN1 |
G protein regulated inducer of neurite outgrowth 1 |
FXC00296
|
FHC00296
|
FNC00296N
|
FNC00296C
|
GPR83 |
G protein-coupled receptor 83 |
FXC00859
|
FHC00859
|
FNC00859N
|
FNC00859C
|
GRIN3A |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
FXC01187
|
FHC01187
|
FNC01187N
|
FNC01187C
|
DHX8 |
DEAH (Asp-Glu-Ala-His) box polypeptide 8, transcript variant 1 |
FXC01202
|
FHC01202
|
FNC01202N
|
FNC01202C
|
GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
FXC01238
|
FHC01238
|
FNC01238N
|
FNC01238C
|
GRIK4 |
glutamate receptor, ionotropic, kainate 4, transcript variant 2 |
FXC01266
|
FHC01266
|
FNC01266N
|
FNC01266C
|
THRB |
thyroid hormone receptor, beta, transcript variant 1 |
FXC01325
|
FHC01325
|
FNC01325N
|
FNC01325C
|
GABRB2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2, transcript variant 2 |
FXC01333
|
FHC01333
|
FNC01333N
|
FNC01333C
|
GRIA3 |
glutamate receptor, ionotropic, AMPA 3, transcript variant 1 |
FXC01359
|
FHC01359
|
FNC01359N
|
FNC01359C
|
GABRA2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2, transcript variant 1 |
FXC01373
|
FHC01373
|
FNC01373N
|
FNC01373C
|
SSTR1 |
somatostatin receptor 1 |
FXC01392
|
FHC01392
|
FNC01392N
|
FNC01392C
|
APLNR |
apelin receptor, transcript variant 1 |
FXC01405
|
FHC01405
|
FNC01405N
|
FNC01405C
|
GRIA2 |
glutamate receptor, ionotropic, AMPA 2, transcript variant 1 |
FXC01427
|
FHC01427
|
FNC01427N
|
FNC01427C
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A, transcript variant 2 |
FXC01444
|
FHC01444
|
FNC01444N
|
FNC01444C
|
GABRD |
gamma-aminobutyric acid (GABA) A receptor, delta |
FXC01489
|
FHC01489
|
FNC01489N
|
FNC01489C
|
SSTR2 |
somatostatin receptor 2 |
FXC01491
|
FHC01491
|
FNC01491N
|
FNC01491C
|
CHRM1 |
cholinergic receptor, muscarinic 1 |
FXC01507
|
FHC01507
|
FNC01507N
|
FNC01507C
|
DRD2 |
dopamine receptor D2, transcript variant 1 |
FXC01519
|
FHC01519
|
FNC01519N
|
FNC01519C
|
S1PR1 |
sphingosine-1-phosphate receptor 1 |
FXC01528
|
FHC01528
|
FNC01528N
|
FNC01528C
|
TSHR |
thyroid stimulating hormone receptor, transcript variant 1 |
FXC01753
|
FHC01753
|
FNC01753N
|
FNC01753C
|
GABRB1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
FXC01799
|
FHC01799
|
FNC01799N
|
FNC01799C
|
S1PR5 |
sphingosine-1-phosphate receptor 5, transcript variant 1 |
|
FHC01802
|
FNC01802N
|
FNC01802C
|
S1PR3 |
sphingosine-1-phosphate receptor 3 |
FXC01830
|
FHC01830
|
FNC01830N
|
FNC01830C
|
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1 |
FXC01880
|
FHC01880
|
FNC01880N
|
FNC01880C
|
GRM4 |
glutamate receptor, metabotropic 4, transcript variant 1 |
FXC01884
|
FHC01884
|
FNC01884N
|
FNC01884C
|
EDNRB |
endothelin receptor type B, transcript variant 1 |
FXC02116
|
FHC02116
|
FNC02116N
|
FNC02116C
|
MCHR1 |
melanin-concentrating hormone receptor 1 |
FXC02170
|
FHC02170
|
FNC02170N
|
FNC02170C
|
P2RY13 |
purinergic receptor P2Y, G-protein coupled, 13 |
FXC02278
|
FHC02278
|
FNC02278N
|
FNC02278C
|
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10, transcript variant 1 |
FXC02280
|
FHC02280
|
FNC02280N
|
FNC02280C
|
LPAR6 |
lysophosphatidic acid receptor 6, transcript variant 1 |
FXC02281
|
FHC02281
|
FNC02281N
|
FNC02281C
|
FPR1 |
formyl peptide receptor 1, transcript variant 2 |
FXC02286
|
FHC02286
|
FNC02286N
|
FNC02286C
|
FPR3 |
formyl peptide receptor 3 |
FXC02287
|
FHC02287
|
FNC02287N
|
FNC02287C
|
AGTR1 |
angiotensin II receptor, type 1, transcript variant 1 |
FXC02288
|
FHC02288
|
FNC02288N
|
FNC02288C
|
CNR2 |
cannabinoid receptor 2 (macrophage) |
FXC02289
|
FHC02289
|
FNC02289N
|
FNC02289C
|
AGTR2 |
angiotensin II receptor, type 2 |
FXC02290
|
FHC02290
|
FNC02290N
|
FNC02290C
|
HTR1E |
5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
FXC02291
|
FHC02291
|
FNC02291N
|
FNC02291C
|
HCRTR2 |
hypocretin (orexin) receptor 2 |
FXC02305
|
FHC02305
|
FNC02305N
|
FNC02305C
|
FSHB |
follicle stimulating hormone, beta polypeptide, transcript variant 1 |
FXC02314
|
FHC02314
|
FNC02314N
|
FNC02314C
|
OPRD1 |
opioid receptor, delta 1 |
FXC02316
|
FHC02316
|
FNC02316N
|
FNC02316C
|
GLP1R |
glucagon-like peptide 1 receptor |
FXC02317
|
FHC02317
|
FNC02317N
|
FNC02317C
|
MLNR |
motilin receptor |
FXC02452
|
FHC02452
|
FNC02452N
|
FNC02452C
|
HCRTR1 |
hypocretin (orexin) receptor 1 |
FXC02641
|
FHC02641
|
FNC02641N
|
FNC02641C
|
PRLR |
prolactin receptor, transcript variant 1 |
FXC02789
|
FHC02789
|
FNC02789N
|
FNC02789C
|
SSTR3 |
somatostatin receptor 3, transcript variant 1 |
FXC02861
|
FHC02861
|
FNC02861N
|
FNC02861C
|
MC2R |
melanocortin 2 receptor (adrenocorticotropic hormone) |
FXC03022
|
FHC03022
|
FNC03022N
|
FNC03022C
|
NPY2R |
neuropeptide Y receptor Y2 |
FXC03041
|
FHC03041
|
FNC03041N
|
FNC03041C
|
NPY5R |
neuropeptide Y receptor Y5 |
FXC03050
|
FHC03050
|
FNC03050N
|
FNC03050C
|
CHRM2 |
cholinergic receptor, muscarinic 2, transcript variant 4 |
FXC03057
|
FHC03057
|
FNC03057N
|
FNC03057C
|
LEP |
leptin |
FXC03079
|
FHC03079
|
FNC03079N
|
FNC03079C
|
ADORA1 |
adenosine A1 receptor, transcript variant 1 |
FXC03111
|
FHC03111
|
FNC03111N
|
FNC03111C
|
ADORA2B |
adenosine A2b receptor |
FXC03114
|
FHC03114
|
FNC03114N
|
FNC03114C
|
PTGFR |
prostaglandin F receptor (FP), transcript variant 1 |
FXC03121
|
FHC03121
|
FNC03121N
|
FNC03121C
|
PTGDR |
prostaglandin D2 receptor (DP), transcript variant 1 |
FXC03122
|
FHC03122
|
FNC03122N
|
FNC03122C
|
F2RL2 |
coagulation factor II (thrombin) receptor-like 2, transcript variant 1 |
FXC03126
|
FHC03126
|
FNC03126N
|
FNC03126C
|
PTGIR |
prostaglandin I2 (prostacyclin) receptor (IP) |
FXC03129
|
FHC03129
|
FNC03129N
|
FNC03129C
|
BDKRB2 |
bradykinin receptor B2 |
FXC03132
|
FHC03132
|
FNC03132N
|
FNC03132C
|
HTR5A |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
FXC03137
|
FHC03137
|
FNC03137N
|
FNC03137C
|
AVPR1A |
arginine vasopressin receptor 1A |
FXC03138
|
FHC03138
|
FNC03138N
|
FNC03138C
|
PTAFR |
platelet-activating factor receptor, transcript variant 3 |
FXC03342
|
FHC03342
|
FNC03342N
|
FNC03342C
|
HTR1F |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
FXC03353
|
FHC03353
|
FNC03353N
|
FNC03353C
|
P2RY1 |
purinergic receptor P2Y, G-protein coupled, 1 |
FXC03355
|
FHC03355
|
FNC03355N
|
FNC03355C
|
NPY4R |
neuropeptide Y receptor Y4, transcript variant 1 |
FXC03357
|
FHC03357
|
FNC03357N
|
FNC03357C
|
P2RY2 |
purinergic receptor P2Y, G-protein coupled, 2, transcript variant 2 |
FXC03359
|
FHC03359
|
FNC03359N
|
FNC03359C
|
HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
FXC03360
|
FHC03360
|
FNC03360N
|
FNC03360C
|
HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
FXC03365
|
FHC03365
|
FNC03365N
|
FNC03365C
|
HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
FXC03369
|
FHC03369
|
FNC03369N
|
FNC03369C
|
ADRA2A |
adrenoceptor alpha 2A |
FXC03371
|
FHC03371
|
FNC03371N
|
FNC03371C
|
AVPR2 |
arginine vasopressin receptor 2, transcript variant 1 |
FXC03500
|
FHC03500
|
FNC03500N
|
FNC03500C
|
SCTR |
secretin receptor |
FXC03512
|
FHC03512
|
FNC03512N
|
FNC03512C
|
EDNRA |
endothelin receptor type A, transcript variant 1 |
FXC03517
|
FHC03517
|
FNC03517N
|
FNC03517C
|
ADORA3 |
adenosine A3 receptor, transcript variant A |
FXC03559
|
FHC03559
|
FNC03559N
|
FNC03559C
|
GABBR1 |
gamma-aminobutyric acid (GABA) B receptor, 1, transcript variant 1 |
FXC03778
|
FHC03778
|
FNC03778N
|
FNC03778C
|
GRIA1 |
glutamate receptor, ionotropic, AMPA 1, transcript variant 1 |
FXC03786
|
FHC03786
|
FNC03786N
|
FNC03786C
|
GRM8 |
glutamate receptor, metabotropic 8, transcript variant 2 |
FXC03787
|
FHC03787
|
FNC03787N
|
FNC03787C
|
ADRA2B |
adrenoceptor alpha 2B |
FXC03869
|
FHC03869
|
FNC03869N
|
FNC03869C
|
DRD3 |
dopamine receptor D3, transcript variant a |
FXC03913
|
FHC03913
|
FNC03913N
|
FNC03913C
|
CCKBR |
cholecystokinin B receptor |
FXC03920
|
FHC03920
|
FNC03920N
|
FNC03920C
|
HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled, transcript variant 2 |
FXC03963
|
FHC03963
|
FNC03963N
|
FNC03963C
|
CCKAR |
cholecystokinin A receptor |
FXC03970
|
FHC03970
|
FNC03970N
|
FNC03970C
|
ADORA2A |
adenosine A2a receptor, transcript variant 3 |
FXC04058
|
FHC04058
|
FNC04058N
|
FNC04058C
|
C3AR1 |
complement component 3a receptor 1 |
FXC04389
|
FHC04389
|
FNC04389N
|
FNC04389C
|
CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
FXC04564
|
FHC04564
|
FNC04564N
|
FNC04564C
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
FXC05358
|
FHC05358
|
FNC05358N
|
FNC05358C
|
GRM1 |
glutamate receptor, metabotropic 1, transcript variant 3 |
FXC05363
|
FHC05363
|
FNC05363N
|
FNC05363C
|
P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4, transcript variant 2 |
FXC06254
|
FHC06254
|
FNC06254N
|
FNC06254C
|
P2RX6 |
purinergic receptor P2X, ligand gated ion channel, 6, transcript variant 1 |
FXC06257
|
FHC06257
|
FNC06257N
|
FNC06257C
|
RXFP2 |
relaxin/insulin-like family peptide receptor 2, transcript variant 1 |
FXC06715
|
FHC06715
|
FNC06715N
|
FNC06715C
|
SSTR5 |
somatostatin receptor 5, transcript variant 1 |
FXC06999
|
FHC06999
|
FNC06999N
|
FNC06999C
|
TAAR2 |
trace amine associated receptor 2, transcript variant 1 |
FXC07049
|
FHC07049
|
FNC07049N
|
FNC07049C
|
TRPV1 |
transient receptor potential cation channel, subfamily V, member 1, transcript variant 2 |
FXC07221
|
FHC07221
|
FNC07221N
|
FNC07221C
|
TSPO |
translocator protein (18kDa), transcript variant PBR |
FXC07231
|
FHC07231
|
FNC07231N
|
FNC07231C
|
MTNR1A |
melatonin receptor 1A |
FXC07731
|
FHC07731
|
FNC07731N
|
FNC07731C
|
THRA |
thyroid hormone receptor, alpha, transcript variant 2 |
FXC07745
|
FHC07745
|
FNC07745N
|
FNC07745C
|
GRID2 |
glutamate receptor, ionotropic, delta 2, transcript variant 1 |
FXC07784
|
FHC07784
|
FNC07784N
|
FNC07784C
|
CHGA |
chromogranin A, transcript variant 1 |
FXC07948
|
FHC07948
|
FNC07948N
|
FNC07948C
|
CHRNB1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
FXC08549
|
FHC08549
|
FNC08549N
|
FNC08549C
|
UBD |
ubiquitin D |
FXC08635
|
FHC08635
|
FNC08635N
|
FNC08635C
|
CTSG |
cathepsin G |
FXC08744
|
FHC08744
|
FNC08744N
|
FNC08744C
|
GZMA |
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
FXC08808
|
FHC08808
|
FNC08808N
|
FNC08808C
|
PRL |
prolactin, transcript variant 1 |
FXC08822
|
FHC08822
|
FNC08822N
|
FNC08822C
|
F2RL1 |
F2R like trypsin receptor 1 |
FXC08944
|
FHC08944
|
FNC08944N
|
FNC08944C
|
FPR2 |
formyl peptide receptor 2, transcript variant 1 |
FXC09276
|
FHC09276
|
FNC09276N
|
FNC09276C
|
GABRA1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1, transcript variant 1 |
FXC09343
|
FHC09343
|
FNC09343N
|
FNC09343C
|
GABRG1 |
gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
FXC09367
|
FHC09367
|
FNC09367N
|
FNC09367C
|
GLRB |
glycine receptor, beta, transcript variant 1 |
FXC09438
|
FHC09438
|
FNC09438N
|
FNC09438C
|
CHRNA5 |
cholinergic receptor, nicotinic, alpha 5 (neuronal), transcript variant 1 |
FXC09483
|
FHC09483
|
FNC09483N
|
FNC09483C
|
BDKRB1 |
bradykinin receptor B1 |
FXC09533
|
FHC09533
|
FNC09533N
|
FNC09533C
|
GLRA3 |
glycine receptor, alpha 3, transcript variant 1 |
FXC09603
|
FHC09603
|
FNC09603N
|
FNC09603C
|
F2R |
coagulation factor II thrombin receptor, transcript variant 1 |
FXC09792
|
FHC09792
|
FNC09792N
|
FNC09792C
|
P2RX7 |
purinergic receptor P2X, ligand-gated ion channel, 7, transcript variant 1 |
FXC09980
|
FHC09980
|
FNC09980N
|
FNC09980C
|
GABRA3 |
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
FXC10228
|
FHC10228
|
FNC10228N
|
FNC10228C
|
CSH1 |
chorionic somatomammotropin hormone 1 (placental lactogen) |
FXC10446
|
FHC10446
|
FNC10446N
|
FNC10446C
|
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), transcript variant 1 |
FXC10483
|
FHC10483
|
FNC10483N
|
FNC10483C
|
CNR1 |
cannabinoid receptor 1 (brain), transcript variant 1 |
FXC10491
|
FHC10491
|
FNC10491N
|
FNC10491C
|
P2RX5 |
purinergic receptor P2X, ligand gated ion channel, 5, transcript variant 1 |
FXC10528
|
FHC10528
|
FNC10528N
|
FNC10528C
|
DRD5 |
dopamine receptor D5 |
FXC10652
|
FHC10652
|
FNC10652N
|
FNC10652C
|
PRSS1 |
protease, serine, 1 (trypsin 1) |
FXC10667
|
FHC10667
|
FNC10667N
|
FNC10667C
|
PRSS3 |
protease, serine, 3, transcript variant 1 |
FXC10679
|
FHC10679
|
FNC10679N
|
FNC10679C
|
CHRM3 |
cholinergic receptor, muscarinic 3 |
FXC10778
|
FHC10778
|
FNC10778N
|
FNC10778C
|
NTSR1 |
neurotensin receptor 1 (high affinity) |
FXC10893
|
FHC10893
|
FNC10893N
|
FNC10893C
|
BRS3 |
bombesin-like receptor 3 |
FXC10903
|
FHC10903
|
FNC10903N
|
FNC10903C
|
CHRNA10 |
cholinergic receptor, nicotinic, alpha 10 (neuronal), transcript variant 1 |
FXC10912
|
FHC10912
|
FNC10912N
|
FNC10912C
|
CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal), transcript variant 1 |
FXC11017
|
FHC11017
|
FNC11017N
|
FNC11017C
|
LPAR1 |
lysophosphatidic acid receptor 1, transcript variant 1 |
FXC11200
|
FHC11200
|
FNC11200N
|
FNC11200C
|
NMUR1 |
neuromedin U receptor 1 |
FXC11244
|
FHC11244
|
FNC11244N
|
FNC11244C
|
MC3R |
melanocortin 3 receptor |
FXC11279
|
FHC11279
|
FNC11279N
|
FNC11279C
|
TAAR6 |
trace amine associated receptor 6 |
FXC11302
|
FHC11302
|
FNC11302N
|
FNC11302C
|
TAAR8 |
trace amine associated receptor 8 |
FXC11303
|
FHC11303
|
FNC11303N
|
FNC11303C
|
OPRK1 |
opioid receptor, kappa 1, transcript variant 1 |
FXC11358
|
FHC11358
|
FNC11358N
|
FNC11358C
|
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
FXC11383
|
FHC11383
|
FNC11383N
|
FNC11383C
|
AVPR1B |
arginine vasopressin receptor 1B |
FXC11387
|
FHC11387
|
FNC11387N
|
FNC11387C
|
GLRA2 |
glycine receptor, alpha 2, transcript variant 1 |
FXC11507
|
FHC11507
|
FNC11507N
|
FNC11507C
|
GABRB3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3, transcript variant 1 |
FXC11524
|
FHC11524
|
FNC11524N
|
FNC11524C
|
PTGER3 |
prostaglandin E receptor 3 (subtype EP3) |
FXC11666
|
FHC11666
|
FNC11666N
|
FNC11666C
|
LTB4R2 |
leukotriene B4 receptor 2, transcript variant 1 |
FXC11715
|
FHC11715
|
FNC11715N
|
FNC11715C
|
GRIA1 |
glutamate receptor, ionotropic, AMPA 1, transcript variant 2 |
FXC11832
|
FHC11832
|
FNC11832N
|
FNC11832C
|
GHSR |
growth hormone secretagogue receptor, transcript variant 1a |
FXC11922
|
FHC11922
|
FNC11922N
|
FNC11922C
|
OPRM1 |
opioid receptor, mu 1 |
FXC11924
|
FHC11924
|
FNC11924N
|
FNC11924C
|
DHX34 |
DEAH (Asp-Glu-Ala-His) box polypeptide 34 |
FXC12090
|
FHC12090
|
FNC12090N
|
FNC12090C
|
CGA |
glycoprotein hormones, alpha polypeptide, transcript variant 2 |
FXC12142
|
FHC12142
|
FNC12142N
|
FNC12142C
|
GABRE |
gamma-aminobutyric acid (GABA) A receptor, epsilon |
FXC12250
|
FHC12250
|
FNC12250N
|
FNC12250C
|
RXFP1 |
relaxin/insulin-like family peptide receptor 1, transcript variant 1 |
FXC12365
|
FHC12365
|
FNC12365N
|
FNC12365C
|
HRH4 |
histamine receptor H4, transcript variant 1 |
FXC12552
|
FHC12552
|
FNC12552N
|
FNC12552C
|
PARD3 |
par-3 family cell polarity regulator, transcript variant 2 |
FXC12690
|
FHC12690
|
FNC12690N
|
FNC12690C
|
GRIK2 |
glutamate receptor, ionotropic, kainate 2 |
FXC15713
|
FHC15713
|
FNC15713N
|
FNC15713C
|
GABRA6 |
gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
FXC15898
|
FHC15898
|
FNC15898N
|
FNC15898C
|
GABRA4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4, transcript variant 1 |
FXC16529
|
FHC16529
|
FNC16529N
|
FNC16529C
|
LEPR |
leptin receptor, transcript variant 1
|
FXC20344
|
FHC20344
|
|
|
PTGER3 |
prostaglandin E receptor 3 (subtype EP3), transcript variant 8 |
FXC20366
|
FHC20366
|
FNC20366N
|
FNC20366C
|
TSHB |
thyroid stimulating hormone, beta, transcript variant 1 |
FXC20489
|
FHC20489
|
FNC20489N
|
FNC20489C
|
CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
FXC20591
|
FHC20591
|
FNC20591N
|
FNC20591C
|
RXFP4 |
relaxin/insulin-like family peptide receptor 4 |
FXC20620
|
FHC20620
|
FNC20620N
|
FNC20620C
|
LHCGR |
luteinizing hormone/choriogonadotropin receptor |
FXC21004
|
FHC21004
|
FNC21004N
|
FNC21004C
|
FSHR |
follicle stimulating hormone receptor, transcript variant 1 |
FXC21005
|
FHC21005
|
FNC21005N
|
FNC21005C
|
TACR1 |
tachykinin receptor 1, transcript variant long |
FXC21063
|
FHC21063
|
FNC21063N
|
FNC21063C
|
CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle), transcript variant 1
|
FXC21232
|
FHC21232
|
|
|
CHRND |
cholinergic receptor, nicotinic, delta (muscle), transcript variant 1 |
FXC21373
|
FHC21373
|
FNC21373N
|
FNC21373C
|
PTH1R |
parathyroid hormone 1 receptor, transcript variant 1 |
FXC21519
|
FHC21519
|
FNC21519N
|
FNC21519C
|
GNRHR |
gonadotropin-releasing hormone receptor, transcript variant 1 |
FXC21930
|
FHC21930
|
FNC21930N
|
FNC21930C
|
RXFP3 |
relaxin/insulin like family peptide receptor 3 |
FXC22137
|
FHC22137
|
FNC22137N
|
FNC22137C
|
HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled, transcript variant b |
FXC22341
|
FHC22341
|
FNC22341N
|
FNC22341C
|
HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled, transcript variant a |
FXC22342
|
FHC22342
|
FNC22342N
|
FNC22342C
|
GLRA1 |
glycine receptor, alpha 1, transcript variant 2 |
FXC22358
|
FHC22358
|
FNC22358N
|
FNC22358C
|
HRH2 |
histamine receptor H2, transcript variant 1 |
FXC22391
|
FHC22391
|
FNC22391N
|
FNC22391C
|
TAAR5 |
trace amine associated receptor 5 |
FXC22757
|
FHC22757
|
FNC22757N
|
FNC22757C
|
TAAR1 |
trace amine associated receptor 1 |
FXC22758
|
FHC22758
|
FNC22758N
|
FNC22758C
|
GHRHR |
growth hormone releasing hormone receptor |
FXC22893
|
FHC22893
|
FNC22893N
|
FNC22893C
|
CHRNA2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal), transcript variant 1 |
FXC23226
|
FHC23226
|
FNC23226N
|
FNC23226C
|
CHRNB3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
FXC23258
|
FHC23258
|
FNC23258N
|
FNC23258C
|
CHRNA6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal), transcript variant 1 |
FXC23259
|
FHC23259
|
FNC23259N
|
FNC23259C
|
TRHR |
thyrotropin-releasing hormone receptor |
FXC23362
|
FHC23362
|
FNC23362N
|
FNC23362C
|
HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled, transcript variant d |
FXC23935
|
FHC23935
|
FNC23935N
|
FNC23935C
|
DRD4 |
dopamine receptor D4 |
FXC24098
|
FHC24098
|
FNC24098N
|
FNC24098C
|
CHRNA3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal), transcript variant 1 |
FXC25478
|
FHC25478
|
FNC25478N
|
FNC25478C
|
CHRNB4 |
cholinergic receptor, nicotinic, beta 4 (neuronal), transcript variant 1 |
FXC25479
|
FHC25479
|
FNC25479N
|
FNC25479C
|
P2RX1 |
purinergic receptor P2X, ligand gated ion channel, 1 |
FXC25833
|
FHC25833
|
FNC25833N
|
FNC25833C
|
CHRNE |
cholinergic receptor, nicotinic, epsilon (muscle) |
FXC25849
|
FHC25849
|
FNC25849N
|
FNC25849C
|
UTS2R |
urotensin 2 receptor |
FXC26230
|
FHC26230
|
FNC26230N
|
FNC26230C
|
HRH4 |
histamine receptor H4, transcript variant 2 |
FXC26277
|
FHC26277
|
FNC26277N
|
FNC26277C
|
GALR1 |
galanin receptor 1 |
FXC26336
|
FHC26336
|
FNC26336N
|
FNC26336C
|
P2RY11 |
purinergic receptor P2Y, G-protein coupled, 11 |
FXC26457
|
FHC26457
|
FNC26457N
|
FNC26457C
|
LPAR2 |
lysophosphatidic acid receptor 2 |
FXC26554
|
FHC26554
|
FNC26554N
|
FNC26554C
|
GRIN2D |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
FXC26720
|
FHC26720
|
FNC26720N
|
FNC26720C
|
ADRA1D |
adrenoceptor alpha 1D |
FXC26901
|
FHC26901
|
FNC26901N
|
FNC26901C
|
HRH3 |
histamine receptor H3 |
FXC27098
|
FHC27098
|
FNC27098N
|
FNC27098C
|
OPRL1 |
opiate receptor-like 1, transcript variant 2 |
FXC27117
|
FHC27117
|
FNC27117N
|
FNC27117C
|
GRPR |
gastrin-releasing peptide receptor |
FXC27311
|
FHC27311
|
FNC27311N
|
FNC27311C
|
LPAR4 |
lysophosphatidic acid receptor 4, transcript variant 2 |
FXC27432
|
FHC27432
|
FNC27432N
|
FNC27432C
|
GABRQ |
gamma-aminobutyric acid (GABA) A receptor, theta |
FXC27555
|
FHC27555
|
FNC27555N
|
FNC27555C
|
CHRFAM7A |
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion, transcript variant 1 |
FXC28291
|
FHC28291
|
FNC28291N
|
FNC28291C
|
CHRFAM7A |
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion, transcript variant 2 |
FXC28292
|
FHC28292
|
FNC28292N
|
FNC28292C
|
CHRNG |
cholinergic receptor, nicotinic, gamma (muscle)
|
FXC28786
|
FHC28786
|
|
|
GRIK1 |
glutamate receptor, ionotropic, kainate 1, transcript variant 2 |
FXC28833
|
FHC28833
|
FNC28833N
|
FNC28833C
|
CHRM4 |
cholinergic receptor, muscarinic 4 |
FXC30477
|
FHC30477
|
FNC30477N
|
FNC30477C
|
GABRA5 |
gamma-aminobutyric acid (GABA) A receptor, alpha 5, transcript variant 1 |
FXC30604
|
FHC30604
|
FNC30604N
|
FNC30604C
|
GH2 |
growth hormone 2, transcript variant 1 |
FXC31562
|
FHC31562
|
FNC31562N
|
FNC31562C
|
GH1 |
growth hormone 1, transcript variant 1 |
FXC31566
|
FHC31566
|
FNC31566N
|
FNC31566C
|
GALR2 |
galanin receptor 2 |
FXC31570
|
FHC31570
|
FNC31570N
|
FNC31570C
|
GALR3 |
galanin receptor 3 |
FXC31600
|
FHC31600
|
FNC31600N
|
FNC31600C
|
F2 |
coagulation factor II (thrombin), transcript variant 1 |
FXC31633
|
FHC31633
|
FNC31633N
|
FNC31633C
|
FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
RNMT |
RNA (guanine-7-) methyltransferase, transcript variant 2 |
FXC00528
|
FHC00528
|
FNC00528N
|
FNC00528C
|
ACKR4 |
atypical chemokine receptor 4, transcript variant 2 |
FXC00538
|
FHC00538
|
FNC00538N
|
FNC00538C
|
CNOT6 |
CCR4-NOT transcription complex, subunit 6 |
FXC00760
|
FHC00760
|
FNC00760N
|
FNC00760C
|
CCR1 |
chemokine (C-C motif) receptor 1 |
FXC00983
|
FHC00983
|
FNC00983N
|
FNC00983C
|
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor), transcript variant 5 |
FXC01260
|
FHC01260
|
FNC01260N
|
FNC01260C
|
CSF2RB |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
FXC01280
|
FHC01280
|
FNC01280N
|
FNC01280C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
BMPR2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
FXC01318
|
FHC01318
|
FNC01318N
|
FNC01318C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
ACVR1B |
activin A receptor, type IB, transcript variant 1 |
FXC01408
|
FHC01408
|
FNC01408N
|
FNC01408C
|
IL6ST |
interleukin 6 signal transducer, transcript variant 1 |
FXC01535
|
FHC01535
|
FNC01535N
|
FNC01535C
|
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b, transcript variant 1 |
FXC01547
|
FHC01547
|
FNC01547N
|
FNC01547C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
CXCL12 |
chemokine (C-X-C motif) ligand 12
|
FXC01580
|
FHC01580
|
|
|
ACKR3 |
atypical chemokine receptor 3 |
FXC01768
|
FHC01768
|
FNC01768N
|
FNC01768C
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, transcript variant 2 |
FXC01839
|
FHC01839
|
FNC01839N
|
FNC01839C
|
FLT1 |
fms-related tyrosine kinase 1, transcript variant 1 |
FXC01847
|
FHC01847
|
FNC01847N
|
FNC01847C
|
IL2RB |
interleukin 2 receptor, beta |
FXC02076
|
FHC02076
|
FNC02076N
|
FNC02076C
|
KITLG |
KIT ligand, transcript variant b |
FXC02130
|
FHC02130
|
FNC02130N
|
FNC02130C
|
EDA |
ectodysplasin A, transcript variant 2 |
FXC02133
|
FHC02133
|
FNC02133N
|
FNC02133C
|
IL3RA |
interleukin 3 receptor, alpha (low affinity), transcript variant 1 |
FXC02171
|
FHC02171
|
FNC02171N
|
FNC02171C
|
INHBA |
inhibin, beta A |
FXC02222
|
FHC02222
|
FNC02222N
|
FNC02222C
|
IFNA16 |
interferon, alpha 16 |
FXC02322
|
FHC02322
|
FNC02322N
|
FNC02322C
|
IFNK |
interferon, kappa |
FXC02335
|
FHC02335
|
FNC02335N
|
FNC02335C
|
BMP2 |
bone morphogenetic protein 2 |
FXC02340
|
FHC02340
|
FNC02340N
|
FNC02340C
|
MPL |
MPL proto-oncogene, thrombopoietin receptor |
FXC02342
|
FHC02342
|
FNC02342N
|
FNC02342C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
IL19 |
interleukin 19, transcript variant 1 |
FXC02467
|
FHC02467
|
FNC02467N
|
FNC02467C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
PRLR |
prolactin receptor, transcript variant 1 |
FXC02789
|
FHC02789
|
FNC02789N
|
FNC02789C
|
OSM |
oncostatin M |
FXC02855
|
FHC02855
|
FNC02855N
|
FNC02855C
|
XCR1 |
chemokine (C motif) receptor 1, transcript variant 1 |
FXC03028
|
FHC03028
|
FNC03028N
|
FNC03028C
|
CXCR6 |
chemokine (C-X-C motif) receptor 6 |
FXC03032
|
FHC03032
|
FNC03032N
|
FNC03032C
|
CCR3 |
chemokine (C-C motif) receptor 3, transcript variant 1 |
FXC03035
|
FHC03035
|
FNC03035N
|
FNC03035C
|
CCR8 |
chemokine (C-C motif) receptor 8 |
FXC03036
|
FHC03036
|
FNC03036N
|
FNC03036C
|
CCR4 |
chemokine (C-C motif) receptor 4 |
FXC03037
|
FHC03037
|
FNC03037N
|
FNC03037C
|
ACKR2 |
atypical chemokine receptor 2 |
FXC03044
|
FHC03044
|
FNC03044N
|
FNC03044C
|
CXCR3 |
chemokine (C-X-C motif) receptor 3, transcript variant 2 |
FXC03047
|
FHC03047
|
FNC03047N
|
FNC03047C
|
LEP |
leptin |
FXC03079
|
FHC03079
|
FNC03079N
|
FNC03079C
|
CCR9 |
chemokine (C-C motif) receptor 9, transcript variant A |
FXC03123
|
FHC03123
|
FNC03123N
|
FNC03123C
|
CXCR5 |
chemokine (C-X-C motif) receptor 5, transcript variant 1 |
FXC03124
|
FHC03124
|
FNC03124N
|
FNC03124C
|
CCR2 |
chemokine (C-C motif) receptor 2, transcript variant A |
FXC03125
|
FHC03125
|
FNC03125N
|
FNC03125C
|
IFNA1 |
interferon, alpha 1 |
FXC03299
|
FHC03299
|
FNC03299N
|
FNC03299C
|
IFNW1 |
interferon, omega 1 |
FXC03302
|
FHC03302
|
FNC03302N
|
FNC03302C
|
CXCR1 |
chemokine (C-X-C motif) receptor 1 |
FXC03346
|
FHC03346
|
FNC03346N
|
FNC03346C
|
CCR5 |
chemokine (C-C motif) receptor 5 (gene/pseudogene), transcript variant A |
FXC03348
|
FHC03348
|
FNC03348N
|
FNC03348C
|
CXCR2 |
chemokine (C-X-C motif) receptor 2, transcript variant 1 |
FXC03352
|
FHC03352
|
FNC03352N
|
FNC03352C
|
BMPR1B |
bone morphogenetic protein receptor, type IB, transcript variant 2 |
FXC03435
|
FHC03435
|
FNC03435N
|
FNC03435C
|
LTBR |
lymphotoxin beta receptor (TNFR superfamily, member 3), transcript variant 1 |
FXC03475
|
FHC03475
|
FNC03475N
|
FNC03475C
|
IL23A |
interleukin 23, alpha subunit p19 |
FXC03630
|
FHC03630
|
FNC03630N
|
FNC03630C
|
LIF |
leukemia inhibitory factor, transcript variant 1 |
FXC03637
|
FHC03637
|
FNC03637N
|
FNC03637C
|
CSF1 |
colony stimulating factor 1 (macrophage), transcript variant 1 |
FXC03695
|
FHC03695
|
FNC03695N
|
FNC03695C
|
EPOR |
erythropoietin receptor, transcript variant 1 |
FXC03734
|
FHC03734
|
FNC03734N
|
FNC03734C
|
IL6R |
interleukin 6 receptor, transcript variant 1 |
FXC03794
|
FHC03794
|
FNC03794N
|
FNC03794C
|
EDAR |
ectodysplasin A receptor |
FXC03799
|
FHC03799
|
FNC03799N
|
FNC03799C
|
CCL14 |
chemokine (C-C motif) ligand 14, transcript variant 3 |
FXC03823
|
FHC03823
|
FNC03823N
|
FNC03823C
|
CCL16 |
chemokine (C-C motif) ligand 16 |
FXC03856
|
FHC03856
|
FNC03856N
|
FNC03856C
|
IFNGR1 |
interferon gamma receptor 1 |
FXC03908
|
FHC03908
|
FNC03908N
|
FNC03908C
|
PF4 |
platelet factor 4 |
FXC03919
|
FHC03919
|
FNC03919N
|
FNC03919C
|
EDA2R |
ectodysplasin A2 receptor, transcript variant 2 |
FXC03935
|
FHC03935
|
FNC03935N
|
FNC03935C
|
IFNAR2 |
interferon (alpha, beta and omega) receptor 2, transcript variant 1 |
FXC03967
|
FHC03967
|
FNC03967N
|
FNC03967C
|
ACVR1 |
activin A receptor, type I, transcript variant 1 |
FXC03971
|
FHC03971
|
FNC03971N
|
FNC03971C
|
TNFRSF13C |
tumor necrosis factor receptor superfamily, member 13C |
FXC03995
|
FHC03995
|
FNC03995N
|
FNC03995C
|
CCL11 |
chemokine (C-C motif) ligand 11 |
FXC04470
|
FHC04470
|
FNC04470N
|
FNC04470C
|
CCL13 |
chemokine (C-C motif) ligand 13 |
FXC04471
|
FHC04471
|
FNC04471N
|
FNC04471C
|
CCL15 |
chemokine (C-C motif) ligand 15 |
FXC04472
|
FHC04472
|
FNC04472N
|
FNC04472C
|
CCL2 |
chemokine (C-C motif) ligand 2 |
FXC04473
|
FHC04473
|
FNC04473N
|
FNC04473C
|
CCL21 |
chemokine (C-C motif) ligand 21 |
FXC04474
|
FHC04474
|
FNC04474N
|
FNC04474C
|
CCL3 |
chemokine (C-C motif) ligand 3 |
FXC04475
|
FHC04475
|
FNC04475N
|
FNC04475C
|
CCL4L1 |
chemokine (C-C motif) ligand 4-like 1, transcript variant CCL4L |
FXC04476
|
FHC04476
|
FNC04476N
|
FNC04476C
|
CCL5 |
chemokine (C-C motif) ligand 5, transcript variant 1 |
FXC04477
|
FHC04477
|
FNC04477N
|
FNC04477C
|
CXCL14 |
chemokine (C-X-C motif) ligand 14 |
FXC04686
|
FHC04686
|
FNC04686N
|
FNC04686C
|
CXCL16 |
chemokine (C-X-C motif) ligand 16, transcript variant 1 |
FXC04687
|
FHC04687
|
FNC04687N
|
FNC04687C
|
CXCL6 |
chemokine (C-X-C motif) ligand 6 |
FXC04688
|
FHC04688
|
FNC04688N
|
FNC04688C
|
EPO |
erythropoietin |
FXC04906
|
FHC04906
|
FNC04906N
|
FNC04906C
|
EPX |
eosinophil peroxidase |
FXC04907
|
FHC04907
|
FNC04907N
|
FNC04907C
|
FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
FXC05491
|
FHC05491
|
FNC05491N
|
FNC05491C
|
IL13 |
interleukin 13 |
FXC05505
|
FHC05505
|
FNC05505N
|
FNC05505C
|
IL17RA |
interleukin 17 receptor A, transcript variant 1 |
FXC05508
|
FHC05508
|
FNC05508N
|
FNC05508C
|
IL1A |
interleukin 1, alpha |
FXC05509
|
FHC05509
|
FNC05509N
|
FNC05509C
|
IL1B |
interleukin 1, beta |
FXC05510
|
FHC05510
|
FNC05510N
|
FNC05510C
|
IFNLR1 |
interferon, lambda receptor 1, transcript variant 1 |
FXC05512
|
FHC05512
|
FNC05512N
|
FNC05512C
|
IL2RG |
interleukin 2 receptor, gamma |
FXC05514
|
FHC05514
|
FNC05514N
|
FNC05514C
|
INHBB |
inhibin, beta B |
FXC05519
|
FHC05519
|
FNC05519N
|
FNC05519C
|
CCR10 |
chemokine (C-C motif) receptor 10 |
FXC05684
|
FHC05684
|
FNC05684N
|
FNC05684C
|
LIFR |
leukemia inhibitory factor receptor alpha, transcript variant 2 |
FXC05827
|
FHC05827
|
FNC05827N
|
FNC05827C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
PPBP |
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
FXC06444
|
FHC06444
|
FNC06444N
|
FNC06444C
|
IL10 |
interleukin 10 |
FXC07552
|
FHC07552
|
FNC07552N
|
FNC07552C
|
IFNE |
interferon, epsilon |
FXC07643
|
FHC07643
|
FNC07643N
|
FNC07643C
|
CXCL12 |
chemokine (C-X-C motif) ligand 12, transcript variant 3 |
FXC07713
|
FHC07713
|
FNC07713N
|
FNC07713C
|
CX3CR1 |
chemokine (C-X3-C motif) receptor 1, transcript variant 1 |
FXC07732
|
FHC07732
|
FNC07732N
|
FNC07732C
|
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
FXC07922
|
FHC07922
|
FNC07922N
|
FNC07922C
|
IL17RB |
interleukin 17 receptor B |
FXC07935
|
FHC07935
|
FNC07935N
|
FNC07935C
|
IL10RB |
interleukin 10 receptor, beta |
FXC08036
|
FHC08036
|
FNC08036N
|
FNC08036C
|
CSF2RA |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage), transcript variant 1 |
FXC08089
|
FHC08089
|
FNC08089N
|
FNC08089C
|
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
FXC08102
|
FHC08102
|
FNC08102N
|
FNC08102C
|
IL21R |
interleukin 21 receptor, transcript variant 1 |
FXC08180
|
FHC08180
|
FNC08180N
|
FNC08180C
|
CXCL11 |
chemokine (C-X-C motif) ligand 11, transcript variant 1 |
FXC08240
|
FHC08240
|
FNC08240N
|
FNC08240C
|
TNFRSF9 |
tumor necrosis factor receptor superfamily, member 9 |
FXC08266
|
FHC08266
|
FNC08266N
|
FNC08266C
|
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
FXC08368
|
FHC08368
|
FNC08368N
|
FNC08368C
|
BMP7 |
bone morphogenetic protein 7 |
FXC08377
|
FHC08377
|
FNC08377N
|
FNC08377C
|
IL13RA1 |
interleukin 13 receptor, alpha 1 |
FXC08469
|
FHC08469
|
FNC08469N
|
FNC08469C
|
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
FXC08484
|
FHC08484
|
FNC08484N
|
FNC08484C
|
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha), transcript variant 1 |
FXC08597
|
FHC08597
|
FNC08597N
|
FNC08597C
|
CD27 |
CD27 molecule |
FXC08615
|
FHC08615
|
FNC08615N
|
FNC08615C
|
CD40 |
CD40 molecule, TNF receptor superfamily member 5, transcript variant 1 |
FXC08629
|
FHC08629
|
FNC08629N
|
FNC08629C
|
TNFRSF10A |
tumor necrosis factor receptor superfamily, member 10a |
FXC08654
|
FHC08654
|
FNC08654N
|
FNC08654C
|
CLCF1 |
cardiotrophin-like cytokine factor 1, transcript variant 1 |
FXC08663
|
FHC08663
|
FNC08663N
|
FNC08663C
|
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
FXC08702
|
FHC08702
|
FNC08702N
|
FNC08702C
|
IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
PRL |
prolactin, transcript variant 1 |
FXC08822
|
FHC08822
|
FNC08822N
|
FNC08822C
|
CX3CL1 |
chemokine (C-X3-C motif) ligand 1, transcript variant 1 |
FXC08831
|
FHC08831
|
FNC08831N
|
FNC08831C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
TNFRSF21 |
tumor necrosis factor receptor superfamily, member 21 |
FXC08912
|
FHC08912
|
FNC08912N
|
FNC08912C
|
TNFSF13B |
tumor necrosis factor (ligand) superfamily, member 13b, transcript variant 1 |
FXC09023
|
FHC09023
|
FNC09023N
|
FNC09023C
|
CCL22 |
chemokine (C-C motif) ligand 22 |
FXC09225
|
FHC09225
|
FNC09225N
|
FNC09225C
|
IL10RA |
interleukin 10 receptor, alpha, transcript variant 1 |
FXC09242
|
FHC09242
|
FNC09242N
|
FNC09242C
|
BMPR1A |
bone morphogenetic protein receptor, type IA |
FXC09257
|
FHC09257
|
FNC09257N
|
FNC09257C
|
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
FXC09319
|
FHC09319
|
FNC09319N
|
FNC09319C
|
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10, transcript variant 1 |
FXC09450
|
FHC09450
|
FNC09450N
|
FNC09450C
|
VEGFC |
vascular endothelial growth factor C |
FXC09559
|
FHC09559
|
FNC09559N
|
FNC09559C
|
CCR7 |
C-C motif chemokine receptor, transcript variant 1 |
FXC09567
|
FHC09567
|
FNC09567N
|
FNC09567C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
CNTFR |
ciliary neurotrophic factor receptor, transcript variant 2 |
FXC09768
|
FHC09768
|
FNC09768N
|
FNC09768C
|
VEGFB |
vascular endothelial growth factor B, transcript variant VEGFB-186 |
FXC09942
|
FHC09942
|
FNC09942N
|
FNC09942C
|
IL24 |
interleukin 24, transcript variant 3 |
FXC09955
|
FHC09955
|
FNC09955N
|
FNC09955C
|
CXCL3 |
chemokine (C-X-C motif) ligand 3 |
FXC10068
|
FHC10068
|
FNC10068N
|
FNC10068C
|
IL15 |
interleukin 15, transcript variant 3 |
FXC10094
|
FHC10094
|
FNC10094N
|
FNC10094C
|
CCL19 |
chemokine (C-C motif) ligand 19 |
FXC10218
|
FHC10218
|
FNC10218N
|
FNC10218C
|
LTA |
lymphotoxin alpha, transcript variant 2 |
FXC10320
|
FHC10320
|
FNC10320N
|
FNC10320C
|
CCR6 |
chemokine (C-C motif) receptor 6, transcript variant 1 |
FXC10350
|
FHC10350
|
FNC10350N
|
FNC10350C
|
CCL20 |
chemokine (C-C motif) ligand 20, transcript variant 2 |
FXC10373
|
FHC10373
|
FNC10373N
|
FNC10373C
|
CSF1R |
colony stimulating factor 1 receptor, transcript variant 1 |
FXC10479
|
FHC10479
|
FNC10479N
|
FNC10479C
|
CCL7 |
chemokine (C-C motif) ligand 7 |
FXC10485
|
FHC10485
|
FNC10485N
|
FNC10485C
|
IFNB1 |
interferon, beta 1, fibroblast |
FXC10486
|
FHC10486
|
FNC10486N
|
FNC10486C
|
IL7 |
interleukin 7, transcript variant 2 |
FXC10487
|
FHC10487
|
FNC10487N
|
FNC10487C
|
IL12A |
interleukin 12A |
FXC10673
|
FHC10673
|
FNC10673N
|
FNC10673C
|
IFNAR1 |
interferon (alpha, beta and omega) receptor 1 |
FXC10692
|
FHC10692
|
FNC10692N
|
FNC10692C
|
TNFRSF11A |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator, transcript variant 1 |
FXC10751
|
FHC10751
|
FNC10751N
|
FNC10751C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4, transcript variant 1 |
FXC10802
|
FHC10802
|
FNC10802N
|
FNC10802C
|
ENC1 |
ectodermal-neural cortex 1 (with BTB domain), transcript variant 1 |
FXC10803
|
FHC10803
|
FNC10803N
|
FNC10803C
|
IL15RA |
interleukin 15 receptor, alpha |
FXC10822
|
FHC10822
|
FNC10822N
|
FNC10822C
|
CCL28 |
chemokine (C-C motif) ligand 28, transcript variant 1 |
FXC10862
|
FHC10862
|
FNC10862N
|
FNC10862C
|
CCL1 |
chemokine (C-C motif) ligand 1 |
FXC10873
|
FHC10873
|
FNC10873N
|
FNC10873C
|
TNFSF14 |
tumor necrosis factor (ligand) superfamily, member 14, transcript variant 1 |
FXC10892
|
FHC10892
|
FNC10892N
|
FNC10892C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
CCL8 |
chemokine (C-C motif) ligand 8 |
FXC10976
|
FHC10976
|
FNC10976N
|
FNC10976C
|
IL2RA |
interleukin 2 receptor, alpha, transcript variant 1 |
FXC11183
|
FHC11183
|
FNC11183N
|
FNC11183C
|
CXCR4 |
chemokine (C-X-C motif) receptor 4, transcript variant 1 |
FXC11275
|
FHC11275
|
FNC11275N
|
FNC11275C
|
TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
FXC11365
|
FHC11365
|
FNC11365N
|
FNC11365C
|
ACVR2A |
activin A receptor, type IIA, transcript variant 2 |
FXC11423
|
FHC11423
|
FNC11423N
|
FNC11423C
|
OSMR |
oncostatin M receptor, transcript variant 1 |
FXC11634
|
FHC11634
|
FNC11634N
|
FNC11634C
|
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
FXC11687
|
FHC11687
|
FNC11687N
|
FNC11687C
|
ACVR2B |
activin A receptor, type IIB |
FXC11748
|
FHC11748
|
FNC11748N
|
FNC11748C
|
CCL27 |
chemokine (C-C motif) ligand 27 |
FXC11762
|
FHC11762
|
FNC11762N
|
FNC11762C
|
CCL25 |
chemokine (C-C motif) ligand 25, transcript variant 2 |
FXC11763
|
FHC11763
|
FNC11763N
|
FNC11763C
|
TNFRSF14 |
tumor necrosis factor receptor superfamily, member 14, transcript variant 1 |
FXC11863
|
FHC11863
|
FNC11863N
|
FNC11863C
|
IL9R |
interleukin 9 receptor |
FXC12238
|
FHC12238
|
FNC12238N
|
FNC12238C
|
IL1R1 |
interleukin 1 receptor, type I, transcript variant 1 |
FXC12556
|
FHC12556
|
FNC12556N
|
FNC12556C
|
IL12RB1 |
interleukin 12 receptor, beta 1, transcript variant 1 |
FXC12558
|
FHC12558
|
FNC12558N
|
FNC12558C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
CCL4 |
chemokine (C-C motif) ligand 4 |
FXC12584
|
FHC12584
|
FNC12584N
|
FNC12584C
|
CRLF2 |
cytokine receptor-like factor 2, transcript variant 1 |
FXC12624
|
FHC12624
|
FNC12624N
|
FNC12624C
|
MET |
MET proto-oncogene, receptor tyrosine kinase, transcript variant 2 |
FXC12649
|
FHC12649
|
FNC12649N
|
FNC12649C
|
CNTF |
ciliary neurotrophic factor |
FXC12716
|
FHC12716
|
FNC12716N
|
FNC12716C
|
VEGFA |
vascular endothelial growth factor A, transcript variant 6 |
FXC13139
|
FHC13139
|
FNC13139N
|
FNC13139C
|
CCM2 |
cerebral cavernous malformation 2 |
FXC13153
|
FHC13153
|
FNC13153N
|
FNC13153C
|
TNFSF18 |
tumor necrosis factor (ligand) superfamily, member 18 |
FXC14055
|
FHC14055
|
FNC14055N
|
FNC14055C
|
IFNA13 |
interferon, alpha 13 |
FXC15894
|
FHC15894
|
FNC15894N
|
FNC15894C
|
TNFRSF4 |
tumor necrosis factor receptor superfamily, member 4 |
FXC20008
|
FHC20008
|
FNC20008N
|
FNC20008C
|
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25, transcript variant 2 |
FXC20050
|
FHC20050
|
FNC20050N
|
FNC20050C
|
TNFRSF1B |
tumor necrosis factor receptor superfamily, member 1B |
FXC20088
|
FHC20088
|
FNC20088N
|
FNC20088C
|
IL22RA1 |
interleukin 22 receptor, alpha 1 |
FXC20138
|
FHC20138
|
FNC20138N
|
FNC20138C
|
LEPR |
leptin receptor, transcript variant 1
|
FXC20344
|
FHC20344
|
|
|
IL23R |
interleukin 23 receptor |
FXC20351
|
FHC20351
|
FNC20351N
|
FNC20351C
|
XCL2 |
chemokine (C motif) ligand 2 |
FXC20701
|
FHC20701
|
FNC20701N
|
FNC20701C
|
IL20 |
interleukin 20 |
FXC20796
|
FHC20796
|
FNC20796N
|
FNC20796C
|
IL1R2 |
interleukin 1 receptor, type II, transcript variant 1 |
FXC21118
|
FHC21118
|
FNC21118N
|
FNC21118C
|
IL18R1 |
interleukin 18 receptor 1, transcript variant 1 |
FXC21121
|
FHC21121
|
FNC21121N
|
FNC21121C
|
IL18RAP |
interleukin 18 receptor accessory protein |
FXC21122
|
FHC21122
|
FNC21122N
|
FNC21122C
|
IL5RA |
interleukin 5 receptor, alpha, transcript variant 1 |
FXC21407
|
FHC21407
|
FNC21407N
|
FNC21407C
|
IL20RB |
interleukin 20 receptor beta |
FXC21704
|
FHC21704
|
FNC21704N
|
FNC21704C
|
THPO |
thrombopoietin, transcript variant 1 |
FXC21783
|
FHC21783
|
FNC21783N
|
FNC21783C
|
IL1RAP |
interleukin 1 receptor accessory protein, transcript variant 1 |
FXC21810
|
FHC21810
|
FNC21810N
|
FNC21810C
|
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
FXC21921
|
FHC21921
|
FNC21921N
|
FNC21921C
|
PF4V1 |
platelet factor 4 variant 1 |
FXC21959
|
FHC21959
|
FNC21959N
|
FNC21959C
|
CXCL13 |
chemokine (C-X-C motif) ligand 13 |
FXC21964
|
FHC21964
|
FNC21964N
|
FNC21964C
|
IL21 |
interleukin 21, transcript variant 1 |
FXC22046
|
FHC22046
|
FNC22046N
|
FNC22046C
|
PDGFC |
platelet derived growth factor C, transcript variant 1 |
FXC22085
|
FHC22085
|
FNC22085N
|
FNC22085C
|
TSLP |
thymic stromal lymphopoietin, transcript variant 1 |
FXC22243
|
FHC22243
|
FNC22243N
|
FNC22243C
|
IL9 |
interleukin 9 |
FXC22288
|
FHC22288
|
FNC22288N
|
FNC22288C
|
IL17B |
interleukin 17B |
FXC22349
|
FHC22349
|
FNC22349N
|
FNC22349C
|
IL12B |
interleukin 12B |
FXC22371
|
FHC22371
|
FNC22371N
|
FNC22371C
|
VEGFA |
vascular endothelial growth factor A
|
FXC22633
|
FHC22633
|
|
|
IL17A |
interleukin 17A |
FXC22655
|
FHC22655
|
FNC22655N
|
FNC22655C
|
CCL26 |
chemokine (C-C motif) ligand 26 |
FXC22957
|
FHC22957
|
FNC22957N
|
FNC22957C
|
TNFRSF10C |
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain |
FXC23212
|
FHC23212
|
FNC23212N
|
FNC23212C
|
TNFRSF10D |
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain |
FXC23213
|
FHC23213
|
FNC23213N
|
FNC23213C
|
IFNA21 |
interferon, alpha 21 |
FXC23475
|
FHC23475
|
FNC23475N
|
FNC23475C
|
IFNA4 |
interferon, alpha 4 |
FXC23476
|
FHC23476
|
FNC23476N
|
FNC23476C
|
IFNA10 |
interferon, alpha 10 |
FXC23477
|
FHC23477
|
FNC23477N
|
FNC23477C
|
IFNA17 |
interferon, alpha 17 |
FXC23478
|
FHC23478
|
FNC23478N
|
FNC23478C
|
IFNA14 |
interferon, alpha 14 |
FXC23479
|
FHC23479
|
FNC23479N
|
FNC23479C
|
IFNA5 |
interferon, alpha 5 |
FXC23480
|
FHC23480
|
FNC23480N
|
FNC23480C
|
IFNA6 |
interferon, alpha 6 |
FXC23481
|
FHC23481
|
FNC23481N
|
FNC23481C
|
IFNA2 |
interferon, alpha 2 |
FXC23482
|
FHC23482
|
FNC23482N
|
FNC23482C
|
IFNA8 |
interferon, alpha 8 |
FXC23483
|
FHC23483
|
FNC23483N
|
FNC23483C
|
TNFSF15 |
tumor necrosis factor (ligand) superfamily, member 15, transcript variant 1 |
FXC23616
|
FHC23616
|
FNC23616N
|
FNC23616C
|
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8, transcript variant 1 |
FXC23617
|
FHC23617
|
FNC23617N
|
FNC23617C
|
AMHR2 |
anti-Mullerian hormone receptor, type II, transcript variant 1 |
FXC24752
|
FHC24752
|
FNC24752N
|
FNC24752C
|
INHBC |
inhibin, beta C |
FXC24781
|
FHC24781
|
FNC24781N
|
FNC24781C
|
INHBE |
inhibin, beta E |
FXC24782
|
FHC24782
|
FNC24782N
|
FNC24782C
|
IFNG |
interferon, gamma |
FXC24802
|
FHC24802
|
FNC24802N
|
FNC24802C
|
IL26 |
interleukin 26 |
FXC24803
|
FHC24803
|
FNC24803N
|
FNC24803C
|
IL22 |
interleukin 22 |
FXC24804
|
FHC24804
|
FNC24804N
|
FNC24804C
|
TNFSF11 |
tumor necrosis factor superfamily member, transcript variant 1 |
FXC24993
|
FHC24993
|
FNC24993N
|
FNC24993C
|
IL25 |
interleukin 25, transcript variant 1 |
FXC25103
|
FHC25103
|
FNC25103N
|
FNC25103C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
IL4R |
interleukin 4 receptor, transcript variant 1 |
FXC25645
|
FHC25645
|
FNC25645N
|
FNC25645C
|
CCL17 |
chemokine (C-C motif) ligand 17 |
FXC25709
|
FHC25709
|
FNC25709N
|
FNC25709C
|
TNFSF12 |
tumor necrosis factor (ligand) superfamily, member 12, transcript variant 1 |
FXC25874
|
FHC25874
|
FNC25874N
|
FNC25874C
|
CCL23 |
chemokine (C-C motif) ligand 23, transcript variant CKbeta8 |
FXC25971
|
FHC25971
|
FNC25971N
|
FNC25971C
|
CCL18 |
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) |
FXC25972
|
FHC25972
|
FNC25972N
|
FNC25972C
|
NGFR |
nerve growth factor receptor
|
FXC26099
|
FHC26099
|
|
|
AMH |
anti-Mullerian hormone |
FXC26382
|
FHC26382
|
FNC26382N
|
FNC26382C
|
MYDGF |
myeloid-derived growth factor |
FXC26407
|
FHC26407
|
FNC26407N
|
FNC26407C
|
TNFSF9 |
tumor necrosis factor (ligand) superfamily, member 9 |
FXC26426
|
FHC26426
|
FNC26426N
|
FNC26426C
|
CD70 |
CD70 molecule |
FXC26427
|
FHC26427
|
FNC26427N
|
FNC26427C
|
IFNL3 |
interferon, lambda 3 |
FXC26621
|
FHC26621
|
FNC26621N
|
FNC26621C
|
IFNL1 |
interferon, lambda 1 |
FXC26622
|
FHC26622
|
FNC26622N
|
FNC26622C
|
FLT3LG |
fms-related tyrosine kinase 3 ligand, transcript variant 3 |
FXC26740
|
FHC26740
|
FNC26740N
|
FNC26740C
|
IL11 |
interleukin 11, transcript variant 1 |
FXC26823
|
FHC26823
|
FNC26823N
|
FNC26823C
|
GDF5 |
growth differentiation factor 5 |
FXC26979
|
FHC26979
|
FNC26979N
|
FNC26979C
|
TNFRSF6B |
tumor necrosis factor receptor superfamily, member 6b, decoy |
FXC27108
|
FHC27108
|
FNC27108N
|
FNC27108C
|
FIGF |
c-fos induced growth factor (vascular endothelial growth factor D) |
FXC27307
|
FHC27307
|
FNC27307N
|
FNC27307C
|
CD40LG |
CD40 ligand |
FXC27535
|
FHC27535
|
FNC27535N
|
FNC27535C
|
FLT3 |
fms-related tyrosine kinase 3, transcript variant 1 |
FXC28201
|
FHC28201
|
FNC28201N
|
FNC28201C
|
CCL3L3 |
chemokine (C-C motif) ligand 3-like 3 |
FXC28460
|
FHC28460
|
FNC28460N
|
FNC28460C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
FXC28990
|
FHC28990
|
FNC28990N
|
FNC28990C
|
CXCL9 |
chemokine (C-X-C motif) ligand 9 |
FXC28992
|
FHC28992
|
FNC28992N
|
FNC28992C
|
CCL24 |
chemokine (C-C motif) ligand 24 |
FXC29239
|
FHC29239
|
FNC29239N
|
FNC29239C
|
IFNA7 |
interferon, alpha 7 |
FXC29362
|
FHC29362
|
FNC29362N
|
FNC29362C
|
IFNL2 |
interferon, lambda 2 |
FXC29927
|
FHC29927
|
FNC29927N
|
FNC29927C
|
IL18 |
interleukin 18, transcript variant 1 |
FXC30506
|
FHC30506
|
FNC30506N
|
FNC30506C
|
XCL1 |
chemokine (C motif) ligand 1 |
FXC31349
|
FHC31349
|
FNC31349N
|
FNC31349C
|
IL2 |
interleukin 2 |
FXC31382
|
FHC31382
|
FNC31382N
|
FNC31382C
|
IL3 |
interleukin 3 |
FXC31395
|
FHC31395
|
FNC31395N
|
FNC31395C
|
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
FXC31396
|
FHC31396
|
FNC31396N
|
FNC31396C
|
IL5 |
interleukin 5 |
FXC31397
|
FHC31397
|
FNC31397N
|
FNC31397C
|
IL4 |
interleukin 4, transcript variant 1 |
FXC31398
|
FHC31398
|
FNC31398N
|
FNC31398C
|
LTB |
lymphotoxin beta (TNF superfamily, member 3), transcript variant 1 |
FXC31407
|
FHC31407
|
FNC31407N
|
FNC31407C
|
TNFSF13 |
tumor necrosis factor (ligand) superfamily, member 13, transcript variant alpha |
FXC31548
|
FHC31548
|
FNC31548N
|
FNC31548C
|
CSF3 |
colony stimulating factor 3 (granulocyte), transcript variant 2 |
FXC31555
|
FHC31555
|
FNC31555N
|
FNC31555C
|
GH2 |
growth hormone 2, transcript variant 1 |
FXC31562
|
FHC31562
|
FNC31562N
|
FNC31562C
|
GH1 |
growth hormone 1, transcript variant 1 |
FXC31566
|
FHC31566
|
FNC31566N
|
FNC31566C
|
IL20RA |
interleukin 20 receptor, alpha, transcript variant 1 |
FXC31740
|
FHC31740
|
FNC31740N
|
FNC31740C
|
TNC |
tenascin C |
FXC00319
|
FHC00319
|
FNC00319N
|
FNC00319C
|
COL4A5 |
collagen, type IV, alpha 5, transcript variant 1
|
FXC00336
|
FHC00336
|
|
|
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
FXC00341
|
FHC00341
|
FNC00341N
|
FNC00341C
|
ITGA7 |
integrin, alpha 7, transcript variant 2 |
FXC01003
|
FHC01003
|
FNC01003N
|
FNC01003C
|
FN1 |
fibronectin 1 |
FXC01189
|
FHC01189
|
FNC01189N
|
FNC01189C
|
LAMA4 |
laminin, alpha 4, transcript variant 1 |
FXC01193
|
FHC01193
|
FNC01193N
|
FNC01193C
|
ITGB7 |
integrin, beta 7, transcript variant 1 |
FXC01226
|
FHC01226
|
FNC01226N
|
FNC01226C
|
LAMB1 |
laminin, beta 1 |
FXC01248
|
FHC01248
|
FNC01248N
|
FNC01248C
|
COL1A2 |
collagen, type I, alpha 2 |
FXC01432
|
FHC01432
|
FNC01432N
|
FNC01432C
|
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
FXC01471
|
FHC01471
|
FNC01471N
|
FNC01471C
|
COL1A1 |
collagen, type I, alpha 1 |
FXC01780
|
FHC01780
|
FNC01780N
|
FNC01780C
|
LAMB3 |
laminin, beta 3, transcript variant 1 |
FXC01782
|
FHC01782
|
FNC01782N
|
FNC01782C
|
COL4A2 |
collagen, type IV, alpha 2 |
FXC01843
|
FHC01843
|
FNC01843N
|
FNC01843C
|
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), transcript variant 1 |
FXC01888
|
FHC01888
|
FNC01888N
|
FNC01888C
|
AGRN |
agrin, transcript variant 2 |
FXC01903
|
FHC01903
|
FNC01903N
|
FNC01903C
|
IBSP |
integrin-binding sialoprotein |
FXC02312
|
FHC02312
|
FNC02312N
|
FNC02312C
|
GP9 |
glycoprotein IX (platelet) |
FXC02986
|
FHC02986
|
FNC02986N
|
FNC02986C
|
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12), transcript variant 1A |
FXC03293
|
FHC03293
|
FNC03293N
|
FNC03293C
|
ITGA2B |
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
FXC03930
|
FHC03930
|
FNC03930N
|
FNC03930C
|
ITGA4 |
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
FXC05544
|
FHC05544
|
FNC05544N
|
FNC05544C
|
ITGAV |
integrin, alpha V, transcript variant 3 |
FXC05547
|
FHC05547
|
FNC05547N
|
FNC05547C
|
SDC1 |
syndecan 1, transcript variant 2 |
FXC06743
|
FHC06743
|
FNC06743N
|
FNC06743C
|
SDC4 |
syndecan 4 |
FXC06745
|
FHC06745
|
FNC06745N
|
FNC06745C
|
COL9A3 |
collagen, type IX, alpha 3 |
FXC08573
|
FHC08573
|
FNC08573N
|
FNC08573C
|
GP1BA |
glycoprotein Ib (platelet), alpha polypeptide |
FXC09227
|
FHC09227
|
FNC09227N
|
FNC09227C
|
TNNC1 |
troponin C type 1 (slow) |
FXC09322
|
FHC09322
|
FNC09322N
|
FNC09322C
|
ITGB5 |
integrin, beta 5 |
FXC10710
|
FHC10710
|
FNC10710N
|
FNC10710C
|
GP5 |
glycoprotein V (platelet) |
FXC10743
|
FHC10743
|
FNC10743N
|
FNC10743C
|
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
FXC10787
|
FHC10787
|
FNC10787N
|
FNC10787C
|
LAMA5 |
laminin, alpha 5 |
FXC10797
|
FHC10797
|
FNC10797N
|
FNC10797C
|
COL6A5 |
collagen, type VI, alpha 5 |
FXC10991
|
FHC10991
|
FNC10991N
|
FNC10991C
|
LAMA2 |
laminin, alpha 2, transcript variant 1 |
FXC12459
|
FHC12459
|
|
|
LAMB2 |
laminin, beta 2 (laminin S) |
FXC12473
|
FHC12473
|
FNC12473N
|
FNC12473C
|
COL9A1 |
collagen, type IX, alpha 1 |
FXC14312
|
FHC14312
|
FNC14312N
|
FNC14312C
|
COL9A2 |
collagen, type IX, alpha 2 |
FXC20248
|
FHC20248
|
FNC20248N
|
FNC20248C
|
HMMR |
hyaluronan-mediated motility receptor (RHAMM), transcript variant 2 |
FXC22380
|
FHC22380
|
FNC22380N
|
FNC22380C
|
LAMC3 |
laminin, gamma 3 |
FXC23683
|
FHC23683
|
FNC23683N
|
FNC23683C
|
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor), transcript variant a
|
FXC26102
|
FHC26102
|
|
|
COMP |
cartilage oligomeric matrix protein |
FXC26548
|
FHC26548
|
FNC26548N
|
FNC26548C
|
LAMA1 |
laminin, alpha 1 |
FXC28523
|
FHC28523
|
FNC28523N
|
FNC28523C
|
RELN |
reelin, transcript variant 1 |
FXC29259
|
FHC29259
|
FNC29259N
|
FNC29259C
|
NRXN3 |
neurexin 3, transcript variant 1 |
FXC00123
|
FHC00123
|
FNC00123N
|
FNC00123C
|
NLGN1 |
neuroligin 1 |
FXC00172
|
FHC00172
|
FNC00172N
|
FNC00172C
|
NLGN3 |
neuroligin 3, transcript variant 3 |
FXC00238
|
FHC00238
|
FNC00238N
|
FNC00238C
|
CNTNAP1 |
contactin associated protein 1 |
FXC00321
|
FHC00321
|
FNC00321N
|
FNC00321C
|
NRXN1 |
neurexin 1
|
FXC00566
|
FHC00566
|
|
|
NRXN2 |
neurexin 2, transcript variant alpha-2 |
FXC00683
|
FHC00683
|
FNC00683N
|
FNC00683C
|
NTNG1 |
netrin G1 |
FXC00705
|
FHC00705
|
FNC00705N
|
FNC00705C
|
FZR1 |
fizzy/cell division cycle 20 related 1, transcript variant 2 |
FXC00776
|
FHC00776
|
FNC00776N
|
FNC00776C
|
NLGN4X |
neuroligin 4, X-linked, transcript variant 1 |
FXC00786
|
FHC00786
|
FNC00786N
|
FNC00786C
|
LRRC4C |
leucine rich repeat containing 4C, transcript variant 1 |
FXC00868
|
FHC00868
|
FNC00868N
|
FNC00868C
|
NTNG2 |
netrin G2 |
FXC00933
|
FHC00933
|
FNC00933N
|
FNC00933C
|
L1CAM |
L1 cell adhesion molecule, transcript variant 1 |
FXC01011
|
FHC01011
|
FNC01011N
|
FNC01011C
|
NRCAM |
neuronal cell adhesion molecule, transcript variant 6 |
FXC01070
|
FHC01070
|
FNC01070N
|
FNC01070C
|
NFASC |
neurofascin, transcript variant 4 |
FXC01119
|
FHC01119
|
FNC01119N
|
FNC01119C
|
PTPRF |
protein tyrosine phosphatase, receptor type, F, transcript variant 2 |
FXC01213
|
FHC01213
|
FNC01213N
|
FNC01213C
|
ITGB7 |
integrin, beta 7, transcript variant 1 |
FXC01226
|
FHC01226
|
FNC01226N
|
FNC01226C
|
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit), transcript variant 2 |
FXC01233
|
FHC01233
|
FNC01233N
|
FNC01233C
|
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal), transcript variant 1 |
FXC01429
|
FHC01429
|
FNC01429N
|
FNC01429C
|
CDH5 |
cadherin 5, type 2 (vascular endothelium) |
FXC01546
|
FHC01546
|
FNC01546N
|
FNC01546C
|
CNTN2 |
contactin 2 (axonal) |
FXC01650
|
FHC01650
|
FNC01650N
|
FNC01650C
|
SDC3 |
syndecan 3 |
FXC01922
|
FHC01922
|
FNC01922N
|
FNC01922C
|
CNTNAP2 |
contactin associated protein-like 2 |
FXC02000
|
FHC02000
|
FNC02000N
|
FNC02000C
|
CD99 |
CD99 molecule, transcript variant 1 |
FXC02678
|
FHC02678
|
FNC02678N
|
FNC02678C
|
JAM2 |
junctional adhesion molecule 2, transcript variant 1 |
FXC02788
|
FHC02788
|
FNC02788N
|
FNC02788C
|
MAG |
myelin associated glycoprotein, transcript variant 1 |
FXC02795
|
FHC02795
|
FNC02795N
|
FNC02795C
|
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12), transcript variant 1A |
FXC03293
|
FHC03293
|
FNC03293N
|
FNC03293C
|
SPN |
sialophorin, transcript variant 2 |
FXC03367
|
FHC03367
|
FNC03367N
|
FNC03367C
|
MPZL1 |
myelin protein zero-like 1, transcript variant 1 |
FXC03571
|
FHC03571
|
FNC03571N
|
FNC03571C
|
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit), transcript variant 1 |
FXC03720
|
FHC03720
|
FNC03720N
|
FNC03720C
|
CDH3 |
cadherin 3, type 1, P-cadherin (placental) |
FXC03727
|
FHC03727
|
FNC03727N
|
FNC03727C
|
SELP |
selectin P (granule membrane protein 140kDa, antigen CD62) |
FXC03728
|
FHC03728
|
FNC03728N
|
FNC03728C
|
PVRL1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C), transcript variant 1 |
FXC03817
|
FHC03817
|
FNC03817N
|
FNC03817C
|
CLDN2 |
claudin 2, transcript variant 1 |
FXC04576
|
FHC04576
|
FNC04576N
|
FNC04576C
|
CLDN5 |
claudin 5 |
FXC04577
|
FHC04577
|
FNC04577N
|
FNC04577C
|
ICAM2 |
intercellular adhesion molecule 2, transcript variant 5 |
FXC05479
|
FHC05479
|
FNC05479N
|
FNC05479C
|
ICAM3 |
intercellular adhesion molecule 3 |
FXC05480
|
FHC05480
|
FNC05480N
|
FNC05480C
|
ITGA4 |
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
FXC05544
|
FHC05544
|
FNC05544N
|
FNC05544C
|
ITGAV |
integrin, alpha V, transcript variant 3 |
FXC05547
|
FHC05547
|
FNC05547N
|
FNC05547C
|
CNTN2 |
contactin 2 (axonal)
|
FXC05988
|
FHC05988
|
|
|
SDC1 |
syndecan 1, transcript variant 2 |
FXC06743
|
FHC06743
|
FNC06743N
|
FNC06743C
|
SDC4 |
syndecan 4 |
FXC06745
|
FHC06745
|
FNC06745N
|
FNC06745C
|
SELPLG |
selectin P ligand, transcript variant 2 |
FXC06759
|
FHC06759
|
FNC06759N
|
FNC06759C
|
DEAF1 |
DEAF1 transcription factor |
FXC07762
|
FHC07762
|
FNC07762N
|
FNC07762C
|
MPZ |
myelin protein zero |
FXC08293
|
FHC08293
|
FNC08293N
|
FNC08293C
|
CDH15 |
cadherin 15, type 1, M-cadherin (myotubule) |
FXC08407
|
FHC08407
|
FNC08407N
|
FNC08407C
|
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
FXC08554
|
FHC08554
|
FNC08554N
|
FNC08554C
|
CD40 |
CD40 molecule, TNF receptor superfamily member 5, transcript variant 1 |
FXC08629
|
FHC08629
|
FNC08629N
|
FNC08629C
|
CLDN1 |
claudin 1 |
FXC08634
|
FHC08634
|
FNC08634N
|
FNC08634C
|
PVR |
poliovirus receptor, transcript variant 1 |
FXC08794
|
FHC08794
|
FNC08794N
|
FNC08794C
|
ESAM |
endothelial cell adhesion molecule |
FXC08863
|
FHC08863
|
FNC08863N
|
FNC08863C
|
CLDN8 |
claudin 8 |
FXC09039
|
FHC09039
|
FNC09039N
|
FNC09039C
|
CD4 |
CD4 molecule, transcript variant 1 |
FXC09175
|
FHC09175
|
FNC09175N
|
FNC09175C
|
CD2 |
CD2 molecule |
FXC09477
|
FHC09477
|
FNC09477N
|
FNC09477C
|
ELF2 |
E74-like factor 2 (ets domain transcription factor), transcript variant 2 |
FXC09540
|
FHC09540
|
FNC09540N
|
FNC09540C
|
NEO1 |
neogenin 1 |
FXC09678
|
FHC09678
|
FNC09678N
|
FNC09678C
|
CLDN14 |
claudin 14, transcript variant epsilon |
FXC09987
|
FHC09987
|
FNC09987N
|
FNC09987C
|
ICAM1 |
intercellular adhesion molecule 1 |
FXC10061
|
FHC10061
|
FNC10061N
|
FNC10061C
|
PECAM1 |
platelet/endothelial cell adhesion molecule 1 |
FXC10159
|
FHC10159
|
FNC10159N
|
FNC10159C
|
CD8A |
CD8a molecule, transcript variant 1
|
FXC10195
|
FHC10195
|
|
|
OCLN |
occludin, transcript variant 1 |
FXC10244
|
FHC10244
|
FNC10244N
|
FNC10244C
|
CD86 |
CD86 molecule, transcript variant 1 |
FXC10363
|
FHC10363
|
FNC10363N
|
FNC10363C
|
ICOSLG |
inducible T-cell co-stimulator ligand, transcript variant 1 |
FXC10427
|
FHC10427
|
FNC10427N
|
FNC10427C
|
F11R |
F11 receptor |
FXC10523
|
FHC10523
|
FNC10523N
|
FNC10523C
|
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3
|
FXC10549
|
FHC10549
|
|
|
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1, transcript variant 1 |
FXC10550
|
FHC10550
|
FNC10550N
|
FNC10550C
|
CLDN7 |
claudin 7, transcript variant 1 |
FXC10648
|
FHC10648
|
FNC10648N
|
FNC10648C
|
PVRL2 |
poliovirus receptor-related 2 (herpesvirus entry mediator B), transcript variant delta |
FXC10685
|
FHC10685
|
FNC10685N
|
FNC10685C
|
ICOS |
inducible T-cell co-stimulator |
FXC10968
|
FHC10968
|
FNC10968N
|
FNC10968C
|
CD34 |
CD34 molecule, transcript variant 1 |
FXC11039
|
FHC11039
|
FNC11039N
|
FNC11039C
|
SELL |
selectin L, transcript variant 1 |
FXC11366
|
FHC11366
|
FNC11366N
|
FNC11366C
|
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
FXC11450
|
FHC11450
|
FNC11450N
|
FNC11450C
|
PTPRC |
protein tyrosine phosphatase, receptor type, C, transcript variant 2 |
FXC11626
|
FHC11626
|
FNC11626N
|
FNC11626C
|
SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
FXC11726
|
FHC11726
|
FNC11726N
|
FNC11726C
|
ITGA8 |
integrin, alpha 8, transcript variant 1 |
FXC11884
|
FHC11884
|
FNC11884N
|
FNC11884C
|
LRRC4 |
leucine rich repeat containing 4 |
FXC11940
|
FHC11940
|
FNC11940N
|
FNC11940C
|
NEGR1 |
neuronal growth regulator 1 |
FXC15216
|
FHC15216
|
FNC15216N
|
FNC15216C
|
VCAM1 |
vascular cell adhesion molecule 1, transcript variant 1 |
FXC20428
|
FHC20428
|
FNC20428N
|
FNC20428C
|
CD58 |
CD58 molecule, transcript variant 1 |
FXC20493
|
FHC20493
|
FNC20493N
|
FNC20493C
|
VTCN1 |
V-set domain containing T cell activation inhibitor 1, transcript variant 1 |
FXC20498
|
FHC20498
|
FNC20498N
|
FNC20498C
|
SELE |
selectin E |
FXC20703
|
FHC20703
|
FNC20703N
|
FNC20703C
|
CD8B |
CD8b molecule, transcript variant 2
|
FXC21088
|
FHC21088
|
|
|
CD28 |
CD28 molecule, transcript variant 1 |
FXC21287
|
FHC21287
|
FNC21287N
|
FNC21287C
|
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4, transcript variant 1 |
FXC21288
|
FHC21288
|
FNC21288N
|
FNC21288C
|
CD80 |
CD80 molecule |
FXC21656
|
FHC21656
|
FNC21656N
|
FNC21656C
|
CLDN16 |
claudin 16 |
FXC21808
|
FHC21808
|
FNC21808N
|
FNC21808C
|
CD274 |
CD274 molecule, transcript variant 1 |
FXC23455
|
FHC23455
|
FNC23455N
|
FNC23455C
|
PDCD1LG2 |
programmed cell death 1 ligand 2 |
FXC23456
|
FHC23456
|
FNC23456N
|
FNC23456C
|
PHOX2A |
paired-like homeobox 2a |
FXC24373
|
FHC24373
|
FNC24373N
|
FNC24373C
|
CD226 |
CD226 molecule, transcript variant 1 |
FXC26327
|
FHC26327
|
FNC26327N
|
FNC26327C
|
MADCAM1 |
mucosal vascular addressin cell adhesion molecule 1, transcript variant 1 |
FXC26351
|
FHC26351
|
FNC26351N
|
FNC26351C
|
CD40LG |
CD40 ligand |
FXC27535
|
FHC27535
|
FNC27535N
|
FNC27535C
|
RBM45 |
RNA binding motif protein 45 |
FXC28752
|
FHC28752
|
FNC28752N
|
FNC28752C
|
PDCD1 |
programmed cell death 1 |
FXC28800
|
FHC28800
|
FNC28800N
|
FNC28800C
|
ALCAM |
activated leukocyte cell adhesion molecule, transcript variant 1 |
FXC28915
|
FHC28915
|
FNC28915N
|
FNC28915C
|